Literature DB >> 18084901

Peroxiredoxins in the lung with emphasis on peroxiredoxin VI.

Bruno Schremmer1, Yefim Manevich, Sheldon I Feinstein, Aron B Fisher.   

Abstract

All six mammalian peroxiredoxins are expressed in the lung. Peroxiredoxin (Prx) VI is the isoform expressed at the highest level and its lung expression exceeds that for other organs. The predominant location of Prx VI is the cytosol and acidic organelles of Clara cells of the conducting airways and type II epithelial cells and macrophages in the alveoli. Prx I and VI show developmental induction of transcription at birth. PrxVI shares structural homology with other peroxiredoxins exhibiting a thioredoxin fold and a conserved catalytic Cys residue in the N-terminus of the protein. This enzyme is highly inducible by oxidative stress in both the neonatal and adult lung consistent with a role in antioxidant defense. Prx VI has several properties that distinguish its peroxidase activity from other peroxiredoxins: it can reduce phospholipid hydroperoxides in addition to other organic hydroperoxides and H2O2; the electron donor that serves to reduce the oxidized peroxidatic cysteine is not thioredoxin but GSH; instead of homodimerization, heterodimerization with pi-glutathione S-transferase is required for regeneration of the active enzyme. Prx VI also expresses a phospholipase A2 activity that is Ca2+-independent, maximal at acidic pH, and dependent on a serine-based catalytic triad and nucleophilic elbow at the surface of the protein. Models of altered Prx VI expression at the cellular, organ and whole animal levels have demonstrated that Prx VI functions as an important anti-oxidant enzyme with levels of protection that exceed those ascribed to GSH peroxidase (GPx1). The phospholipase A2 activity plays an important role in lung surfactant homeostasis and is responsible for the bulk of the degradation of internalized phosphatidylcholine and its resynthesis by the reacylation pathway. Expression of peroxiredoxins is elevated in several lung diseases including lung cancer, mesothelioma and sarcoidosis, although the mechanism for these alterations is not known. The unique properties of Prx VI enable it to play an important role in lung cell function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18084901     DOI: 10.1007/978-1-4020-6051-9_15

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  24 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Comparison of glutathione peroxidase 1 and peroxiredoxin 6 in protection against oxidative stress in the mouse lung.

Authors:  Geng Liu; Sheldon I Feinstein; Yan Wang; Chandra Dodia; Donald Fisher; Kevin Yu; Ye-Shih Ho; Aron B Fisher
Journal:  Free Radic Biol Med       Date:  2010-07-11       Impact factor: 7.376

3.  Functional interaction of glutathione S-transferase pi and peroxiredoxin 6 in intact cells.

Authors:  Suiping Zhou; Yu-Chin Lien; Tea Shuvaeva; Kristine DeBolt; Sheldon I Feinstein; Aron B Fisher
Journal:  Int J Biochem Cell Biol       Date:  2012-11-16       Impact factor: 5.085

4.  Changes in protein expression in the salt marsh mussel Geukensia demissa: evidence for a shift from anaerobic to aerobic metabolism during prolonged aerial exposure.

Authors:  Peter A Fields; Chris Eurich; William L Gao; Bekim Cela
Journal:  J Exp Biol       Date:  2014-02-05       Impact factor: 3.312

Review 5.  Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities.

Authors:  Aron B Fisher
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

6.  Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3ε.

Authors:  Elena M Sorokina; Sheldon I Feinstein; Suiping Zhou; Aron B Fisher
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-23       Impact factor: 4.249

Review 7.  Basic principles and emerging concepts in the redox control of transcription factors.

Authors:  Regina Brigelius-Flohé; Leopold Flohé
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

Review 8.  Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.

Authors:  Evan A Elko; Brian Cunniff; David J Seward; Shi Biao Chia; Reem Aboushousha; Cheryl van de Wetering; Jos van der Velden; Allison Manuel; Arti Shukla; Nicholas H Heintz; Vikas Anathy; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

9.  A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.

Authors:  Intae Lee; Chandra Dodia; Shampa Chatterjee; John Zagorski; Clementina Mesaros; Ian A Blair; Sheldon I Feinstein; Mahendra Jain; Aron B Fisher
Journal:  J Pharmacol Exp Ther       Date:  2013-03-08       Impact factor: 4.030

Review 10.  The serpentine path to a novel mechanism-based inhibitor of acute inflammatory lung injury.

Authors:  Aron B Fisher
Journal:  J Appl Physiol (1985)       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.